Peer Review reports
From: miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1
Original Submission | ||
---|---|---|
7 Jan 2020 | Submitted | Original manuscript |
20 Feb 2020 | Reviewed | Reviewer Report |
17 Mar 2020 | Reviewed | Reviewer Report - Zhengyu Zha |
31 Mar 2020 | Reviewed | Reviewer Report - Jiping Zeng |
5 Jun 2020 | Author responded | Author comments - Yang Meng |
Resubmission - Version 2 | ||
5 Jun 2020 | Submitted | Manuscript version 2 |
3 Aug 2020 | Reviewed | Reviewer Report |
11 Sep 2020 | Reviewed | Reviewer Report |
26 Sep 2020 | Author responded | Author comments - Yang Meng |
Resubmission - Version 3 | ||
26 Sep 2020 | Submitted | Manuscript version 3 |
Publishing | ||
29 Sep 2020 | Editorially accepted | |
27 Oct 2020 | Article published | 10.1186/s12885-020-07472-2 |
You can find further information about peer review here.